Christopher H. Lowrey

2.3k total citations
59 papers, 1.9k citations indexed

About

Christopher H. Lowrey is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Christopher H. Lowrey has authored 59 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 25 papers in Genetics and 12 papers in Hematology. Recurrent topics in Christopher H. Lowrey's work include Hemoglobinopathies and Related Disorders (17 papers), Epigenetics and DNA Methylation (15 papers) and RNA modifications and cancer (10 papers). Christopher H. Lowrey is often cited by papers focused on Hemoglobinopathies and Related Disorders (17 papers), Epigenetics and DNA Methylation (15 papers) and RNA modifications and cancer (10 papers). Christopher H. Lowrey collaborates with scholars based in United States, United Kingdom and Czechia. Christopher H. Lowrey's co-authors include Elizabeth R. Macari, Rodwell Mabaera, Arthur W. Nienhuis, Alan F. Horwitz, Armando R. Tovar, C H Damsky, Nicola T. Neff, Cindi Decker, C A Buck and Cynthia K. Hahn and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Christopher H. Lowrey

57 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher H. Lowrey United States	24	1.1k	556	388	308	265	59	1.9k
Stefan Florian Austria	23	746 0.7×	249 0.4×	391 1.0×	317 1.0×	680 2.6×	47	1.8k
Véronique Mansat‐De Mas France	25	1.3k 1.1×	546 1.0×	1.4k 3.7×	428 1.4×	358 1.4×	57	2.5k
Kenneth S. Zuckerman United States	24	598 0.5×	330 0.6×	469 1.2×	318 1.0×	343 1.3×	67	1.5k
Jiro Kikuchi Japan	27	1.5k 1.3×	153 0.3×	685 1.8×	594 1.9×	352 1.3×	89	2.2k
Thomas Oellerich Germany	27	1.1k 1.0×	274 0.5×	527 1.4×	333 1.1×	503 1.9×	87	2.0k
Thamar B. van Dijk Netherlands	22	867 0.8×	212 0.4×	150 0.4×	471 1.5×	435 1.6×	36	1.5k
Jasper de Boer United Kingdom	22	1.2k 1.1×	143 0.3×	477 1.2×	342 1.1×	787 3.0×	43	2.2k
Adrienne A. Hilton Australia	15	1.4k 1.2×	208 0.4×	488 1.3×	379 1.2×	453 1.7×	18	2.3k
Alison M. Michie United Kingdom	27	1.2k 1.1×	347 0.6×	463 1.2×	486 1.6×	1.0k 3.9×	67	2.5k

Countries citing papers authored by Christopher H. Lowrey

Since Specialization

Citations

This map shows the geographic impact of Christopher H. Lowrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher H. Lowrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher H. Lowrey more than expected).

Fields of papers citing papers by Christopher H. Lowrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher H. Lowrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher H. Lowrey. The network helps show where Christopher H. Lowrey may publish in the future.

Co-authorship network of co-authors of Christopher H. Lowrey

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher H. Lowrey. A scholar is included among the top collaborators of Christopher H. Lowrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher H. Lowrey. Christopher H. Lowrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meehan, Kenneth R., et al.. (2020). Caregivers’ Out-of-Pocket Expenses and Time Commitment Following Hematopoietic Stem Cell Transplantation at a Rural Cancer Center. Biology of Blood and Marrow Transplantation. 26(9). e227–e231. 15 indexed citations

Deng, Jie, Jiannan Li, Aurélien Sarde, et al.. (2019). Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Cancer Immunology Research. 7(7). 1079–1090. 164 indexed citations

Lowrey, Christopher H., et al.. (2019). Severe acquired platelet dysfunction because of primary myelofibrosis with full functional and morphological recovery after allogeneic hematopoietic cell transplantation. Blood Coagulation & Fibrinolysis. 30(8). 419–422. 1 indexed citations

Hill, John M., et al.. (2015). Hospital readmission following transplantation: identifying risk factors and designing preventive measures. The Journal of Community and Supportive Oncology. 13(9). 316–322. 13 indexed citations

Hahn, Cynthia K. & Christopher H. Lowrey. (2014). Induction of fetal hemoglobin through enhanced translation efficiency of γ-globin mRNA. Blood. 124(17). 2730–2734. 28 indexed citations

Bates, Darcy, Alexey V. Danilov, Christopher H. Lowrey, & Alan Eastman. (2013). Vinblastine Rapidly Induces NOXA and Acutely Sensitizes Primary Chronic Lymphocytic Leukemia Cells to ABT-737. Molecular Cancer Therapeutics. 12(8). 1504–1514. 29 indexed citations

Schaeffer, Emily K., et al.. (2013). Multiple physical stresses induce γ-globin gene expression and fetal hemoglobin production in erythroid cells. Blood Cells Molecules and Diseases. 52(4). 214–224. 10 indexed citations

Boosalis, Michael S., Serguei A. Castañeda, Marie Trudel, et al.. (2011). Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo. Blood Cells Molecules and Diseases. 47(2). 107–116. 15 indexed citations

Bates, Darcy, et al.. (2011). Vinblastine sensitizes leukemia cells to cyclin-dependent kinase inhibitors, inducing acute cell cycle phase-independent apoptosis. Cancer Biology & Therapy. 12(4). 314–325. 22 indexed citations

10.

Lathrop, Melissa J., Christine Richardson, Emmanuel Olivier, et al.. (2009). Developmentally regulated extended domains of DNA hypomethylation encompass highly transcribed genes of the human β-globin locus. Experimental Hematology. 37(7). 807–813.e2. 13 indexed citations

11.

Richardson, Christine, Emmanuel Olivier, Caihong Qiu, et al.. (2009). Complex developmental patterns of histone modifications associated with the human β-globin switch in primary cells. Experimental Hematology. 37(7). 799–806.e4. 12 indexed citations

12.

Venkatesan, Priya, et al.. (2006). The effects of lead and cadmium on GATA-1 regulated erythroid gene expression. Blood Cells Molecules and Diseases. 37(3). 164–172. 3 indexed citations

13.

Horner, Alan, Terryl Stacy, Christopher H. Lowrey, et al.. (2002). The core-binding factor β subunit is required for bone formation and hematopoietic maturation. Nature Genetics. 32(4). 645–649. 133 indexed citations

14.

Nemeth, Michael J., et al.. (2001). An Erythroid-Specific Chromatin Opening Element Reorganizes β-Globin Promoter Chromatin Structure and Augments Gene Expression. Blood Cells Molecules and Diseases. 27(4). 767–780. 4 indexed citations

15.

Lowrey, Christopher H., et al.. (2000). Long-term silencing of retroviral vectors is resistant to reversal by trichostatin A and 5-azacytidine. Gene Therapy. 7(8). 653–663. 32 indexed citations

16.

Nemeth, Michael J., et al.. (1999). Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of β -Thalassemia and Sickle Cell Disease. Hematology. 4(5). 437–455. 1 indexed citations

17.

Iler, Nancy, et al.. (1999). Targeted Remodeling of Human β-Globin Promoter Chromatin Structure Produces Increased Expression and Decreased Silencing. Blood Cells Molecules and Diseases. 25(1). 47–60. 8 indexed citations

18.

Benbow, Ulrike, Joni L. Rutter, Christopher H. Lowrey, & Constance Brinckerhoff. (1998). Transcriptional repression of the human collagenase-1 (MMP-1) gene in MDA231 breast cancer cells by all-trans-retinoic acid requires distal regions of the promoter. British Journal of Cancer. 79(2). 221–228. 27 indexed citations

19.

Lowrey, Christopher H. & Arthur W. Nienhuis. (1993). Treatment with Azacitidine of Patients with End-Stage β-Thalassemia. New England Journal of Medicine. 329(12). 845–848. 103 indexed citations

20.

Baum, Michael, et al.. (1988). The relationship between histological grade, oestrogen receptor status, events and survival at 8 years in the NATO ('Nolvadex') trial. British Journal of Cancer. 57(6). 612–614. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact